Divarasib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Divarasib

Jan 10, 2024, 18:21 | Blog

Top Precision Oncology articles of 2023 by Vivek Subbiah

Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…

Aug 27, 2023, 18:58 | Insight

Vivek Subbiah: The 3rd KRAS G12C kid on the block.

According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:…

Aug 27, 2023, 18:50 | Insight

Anirban Maitra: The phase 1 data of Genentech’s KRAS G12C inhibitor Divarasib was published yesterday in NEJM.

In a Twitter post by Anirban Maitra, a Professor of Pathology and Translational Molecular Pathology,…

All: 3 Posts: 1 - 100

'

FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

'

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023